Marc Beer Is In The Industry For Medical Advancement

There is quite a lot of competition in the biotech industry, which is also a surprising fact given the complexity that is involved in the research as well as the growth of a biotech organization. Marc Beer is currently the head of Renovia Inc, a biotech company that he started up just two years ago in the hopes of developing new treatments for diseases out there plaguing millions. Marc Beer is the co-founder of the company and CEO and currently is focused on raising the funds at Renovia through funding rounds. The latest series of funding by Marc Beer pulled in a hefty 40 million plus in new money that ...

Alex Pall: A City DJ turned Musical Icon

Alex Pall is a young dreamer from New York City. Today, he Is known as one of the members of the duo The Chainsmokers, along with Drew Taggart, but years before his fame, he lived a very different life. Before becoming a world-famous musician, he initially became an assistant at a local art gallery. It is his job to check the artworks for damages and to see if something is missing. He is being paid well, and that is the reason why he never pursued any other career. However, it dawned on him that he wanted to make another career, but only as a sideline. He worked at several bars ...

Scott Rocklage Fights Genetic Disorders

5AM Ventures, founded by Scott M. Rocklage, Ph.D., is one of three major funding sources for this research at Expansion Therapeutics. Together they are investing $55.3 million to fight myotonic disorders.   The symptoms of this type of muscular dystrophy type I (DMI) are evident when RNA levels inside the cells reach toxic levels. Research has been performed at the Matthew D. Disney Laboratory. Dr. Disney is the lead researcher for this team.   Dr. Rocklage and Expansion Therapeutics strive to innovate treatment protocols with small molecule medicines which target RNA. Currently, there is no cure for this genetic disorder. It can affect entire families with each generation becoming worse. ...

Championing A Cure For Muscular Dystrophy and other Genetic Diseases: Scott Rockledge

The life sciences have always been a passionate pursuit for Scott Rockledge. His expertise is in healthcare management. He has worked with Cubist Pharmaceuticals in testing effective treatments and drug trials for genetic disorders. He also worked in research and development at Salutar and Catalytica for a number of clinical trials. His accomplishments include the FDA approval of three new drug applications for Omniscan™, Teslascan®, and Cubicin®.   Rockledge’s experience in life science management, specifically in the pharmaceutical industry, led him to join 5AM Ventures in 2003. 5AM Ventures utilizes a hands-on approach when investing in entrepreneurs in the healthcare industry. This hands-on approach has recently provided much-needed support for ...